UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 322

Sortiert nach

Association between HER2 status in residual disease and sensitivity to trastuzumab emtansine

Annals of oncology, 2021-09, Vol.32 (9), p.1191-1191

Altundag, K.

2021

Volltextzugriff (PDF)

No studies

British dental journal, 2018-02, Vol.224 (4), p.198-198

Altundag, K

2018

Volltextzugriff (PDF)

Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer

European journal of surgical oncology, 2017-06, Vol.43 (6), p.1142-1142

Altundag, Kadri

2017

Volltextzugriff (PDF)

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Journal of bone and mineral research, 2008-06, Vol.23 (6), p.826-836

2008

Volltextzugriff (PDF)

1856 Long term follow up results of patients with ER (+) breast cancer with respect to other receptors status

European journal of cancer (1990), 2015-09, Vol.51, p.S284-S284

2015

Volltextzugriff (PDF)

Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index

British journal of cancer, 2012-11, Vol.107 (11), p.1815-1819

2012

Volltextzugriff (PDF)

Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs)

Annals of oncology, 2018-10, Vol.29, p.viii91-viii91

2018

Volltextzugriff (PDF)

1807 Effect of regular exercise on survival in women with early stage luminal a breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S267-S267

2015

Volltextzugriff (PDF)

716 Predictive value of dynamic and dual 18 FDG PET/CT parameters in the assessment of neoadjuvant chemotherapy response in locally advanced breast cancer: A comparative study with contrast enhanced dynamic MRI

European journal of cancer (1990), 2015-09, Vol.51, p.S132-S132

2015

Volltextzugriff (PDF)

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience

Annals of oncology, 2007-11, Vol.18 (11), p.1904-1906

2007

Volltextzugriff (PDF)

1966 Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2-positive early breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S322-S322

2015

Volltextzugriff (PDF)

The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women

Journal of B.U. ON., 2013-04, Vol.18 (2), p.335-341

2013

Volltextzugriff (PDF)

Neutrophil lymphocyte ratio predicts postoperative pain after orthognathic surgery

Nigerian journal of clinical practice, 2017-10, Vol.20 (10), p.1242-1245

2017

Volltextzugriff (PDF)

P214 Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes

Breast (Edinburgh), 2015-03, Vol.24, p.S99-S99

2015

Volltextzugriff (PDF)

Clinical and pathological characteristics of occult breast cancer and review of the literature

Journal of B.U. ON., 2011-07, Vol.16 (3), p.434

2011

Volltextzugriff (PDF)

Long-term survivors among breast cancer patients with brain metastases

Annals of oncology, 2010-05, Vol.21 (5), p.1128-1128

2010

Volltextzugriff (PDF)

PO-0699: Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma

Radiotherapy and oncology, 2014, Vol.111, p.S21-S21

2014

Volltextzugriff (PDF)

Promising therapeutic options in triple-negative breast cancer

Journal of B.U. ON., 2012-04, Vol.17 (2), p.209-222

2012

Volltextzugriff (PDF)

A case of familial nasopharyngeal carcinoma: is screening necessary for siblings?

Journal of B.U. ON., 2012-04, Vol.17 (2), p.398

2012

Volltextzugriff (PDF)

How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

Annals of oncology, 2008-06, Vol.19 (6), p.1203-1203

2008

Volltextzugriff (PDF)

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy

Journal of B.U. ON., 2013-01, Vol.18 (1), p.289-289

2013

Volltextzugriff (PDF)

Bisphosphonate-associated orbital inflammation: is it class-specific side effect?

Journal of B.U. ON., 2017-11, Vol.22 (6), p.1603-1603

Altundag, Kadri

2017

Volltextzugriff (PDF)

Bone morphogenetic proteins and zoledronic acid

Annals of oncology, 2009-12, Vol.20 (12), p.2019-2019

2009

Volltextzugriff (PDF)

Vemurafenib-induced hypertension: is it real?

Journal of B.U. ON., 2013-04, Vol.18 (2), p.545-545

2013

Volltextzugriff (PDF)

Temozolomide-related infections: review of the literature

Journal of B.U. ON., 2011-07, Vol.16 (3), p.547

2011

Volltextzugriff (PDF)

1 – 25 von 322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(234)
Life Sciences & Biomedicine
(233)
Humans
(222)
Oncology
(149)
Female
(141)
Adult
(68)
Middle Aged
(65)
Male
(59)
Breast Neoplasms - Drug Therapy
(52)
Breast Neoplasms - Pathology
(51)
Aged
(45)
Prognosis
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(34)
Treatment Outcome
(33)
Breast Cancer
(31)
Medicine, Research & Experimental
(26)
Research & Experimental Medicine
(26)
Biological And Medical Sciences
(25)
Medical Sciences
(24)
Retrospective Studies
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between HER2 status in residual disease and sensitivity to trastuzumab emtansine

No studies

Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

1856 Long term follow up results of patients with ER (+) breast cancer with respect to other receptors status

Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index

Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs)

1807 Effect of regular exercise on survival in women with early stage luminal a breast cancer

716 Predictive value of dynamic and dual 18 FDG PET/CT parameters in the assessment of neoadjuvant chemotherapy response in locally advanced breast cancer: A comparative study with contrast enhanced dynamic MRI

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience

1966 Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2-positive early breast cancer

The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women

Neutrophil lymphocyte ratio predicts postoperative pain after orthognathic surgery

P214 Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes

Clinical and pathological characteristics of occult breast cancer and review of the literature

Long-term survivors among breast cancer patients with brain metastases

PO-0699: Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma

Promising therapeutic options in triple-negative breast cancer

A case of familial nasopharyngeal carcinoma: is screening necessary for siblings?

How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy

Bisphosphonate-associated orbital inflammation: is it class-specific side effect?

Bone morphogenetic proteins and zoledronic acid

Vemurafenib-induced hypertension: is it real?

Temozolomide-related infections: review of the literature

Suchergebnisse filtern